Anticorps Recombinant de lapin anti-VRK2
VRK2 Recombinant Antibody for WB, Cytometric bead array, Indirect ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain
Applications
WB, Cytometric bead array, Indirect ELISA
Conjugaison
Non conjugué
CloneNo.
242180B2
N° de cat : 84663-1-PBS
Synonymes
Galerie de données de validation
Informations sur le produit
84663-1-PBS cible VRK2 dans les applications de WB, Cytometric bead array, Indirect ELISA et montre une réactivité avec des échantillons Humain
| Réactivité | Humain |
| Hôte / Isotype | Lapin / IgG |
| Clonalité | Recombinant |
| Type | Anticorps |
| Immunogène | VRK2 Protéine recombinante Ag4019 |
| Nom complet | vaccinia related kinase 2 |
| Masse moléculaire calculée | 508 aa, 58 kDa |
| Poids moléculaire observé | 58 kDa |
| Numéro d’acquisition GenBank | BC027854 |
| Symbole du gène | VRK2 |
| Identification du gène (NCBI) | 7444 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Purification par protéine A |
| Tampon de stockage | PBS only |
| Conditions de stockage | Store at -80°C. 20ul contiennent 0,1% de BSA. |
Informations générales
Vaccinia-related kinase 2 (VRK2) is a serine/threonine kinase that plays a significant role in various cellular processes, including cell survival, proliferation, and DNA damage response. The VRK2 gene is known to produce two main splice variants: VRK2A and VRK2B, with VRK2A being the predominant form in humans. VRK2 is involved in several key biological functions. It is known to enhance cell survival by acting as an anti-apoptotic factor, which is particularly crucial in cancer biology. The overexpression of VRK2 has been linked to increased drug sensitivity in cancer cells, suggesting that this kinase may play a role in therapeutic responses. Additionally, high levels of VRK2 protein have been associated with improved survival rates in specific subgroups of astrocytomas, a type of brain tumor. (PMID: 29872222; 37943248; 24079673)





